Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT03169335 · COMPLETED
Trial details
- NCT number
- NCT03169335
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-28
- Primary completion
- 2018-06-23
- Enrollment
- 535
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.